Hetero Labs Ltd Iii Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HETERO LABS LTD III, and what generic and branded alternatives to HETERO LABS LTD III drugs are available?
HETERO LABS LTD III has sixty-eight approved drugs.
There are four tentative approvals on HETERO LABS LTD III drugs.
Drugs and US Patents for Hetero Labs Ltd Iii
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hetero Labs Ltd Iii | POSACONAZOLE | posaconazole | TABLET, DELAYED RELEASE;ORAL | 214321-001 | Dec 8, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hetero Labs Ltd Iii | DIMETHYL FUMARATE | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 210500-001 | Sep 24, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hetero Labs Ltd Iii | FINASTERIDE | finasteride | TABLET;ORAL | 090060-001 | Jul 1, 2013 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hetero Labs Ltd Iii | TORSEMIDE | torsemide | TABLET;ORAL | 079234-001 | Jan 27, 2009 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for HETERO LABS LTD III drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.